United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read General business news DL Holdings acquires full control of DL Family Office for HK$220m DL Holdings Group Limited has announced the acquisition of the remaining 55% stake in DL Family Office (HK)… byPallavi MadhirajuSeptember 17, 2023